Cargando…
Biomaterials-based anti-inflammatory treatment strategies for Alzheimer’s disease
The current therapeutic drugs for Alzheimer’s disease only improve symptoms, they do not delay disease progression. Therefore, there is an urgent need for new effective drugs. The underlying pathogenic factors of Alzheimer’s disease are not clear, but neuroinflammation can link various hypotheses of...
Autores principales: | Chu, Jianjian, Zhang, Weicong, Liu, Yan, Gong, Baofeng, Ji, Wenbo, Yin, Tong, Gao, Chao, Liangwen, Danqi, Hao, Mengqi, Chen, Cuimin, Zhuang, Jianhua, Gao, Jie, Yin, You |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479833/ https://www.ncbi.nlm.nih.gov/pubmed/37488851 http://dx.doi.org/10.4103/1673-5374.374137 |
Ejemplares similares
-
Cell primitive-based biomimetic nanomaterials for Alzheimer's disease targeting and therapy
por: Yin, Tong, et al.
Publicado: (2023) -
Engineered mesenchymal stem cell-derived extracellular vesicles: A state-of-the-art multifunctional weapon against Alzheimer's disease
por: Yin, Tong, et al.
Publicado: (2023) -
Hydrogel: A Promising New Technique for Treating Alzheimer’s Disease
por: Gong, Baofeng, et al.
Publicado: (2022) -
The Long and the Short of Current Nanomedicines for Treating Alzheimer's Disease
por: Gong, Baofeng, et al.
Publicado: (2023) -
Nanoparticles-based anti-aging treatment of Alzheimer’s disease
por: Chu, Jian-Jian, et al.
Publicado: (2022)